Revelation Biosciences earnings were -$15.0M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest REVB earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$1.7M, down 23% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, REVB reported annual earnings of -$15.0M, with 12,405.6% growth. The next REVB earnings date is May 8, 2025.
Revelation Biosciences Earnings Reports & History FAQ
What were Revelation Biosciences's earnings last quarter?
On REVB's earnings call on Invalid Date, Revelation Biosciences (NASDAQ: REVB) reported Q4 2024 earnings per share (EPS) of $30.40, up 118.72% year over year. Total REVB earnings for the quarter were -$1.73 million. In the same quarter last year, Revelation Biosciences's earnings per share (EPS) was -$162.36.
The next REVB earnings date is Invalid Date. Add REVB to your watchlist to be reminded of Revelation Biosciences's next earnings date.
What was REVB's earnings growth in the past year?
As of Revelation Biosciences's earnings date in Invalid Date, Revelation Biosciences's earnings has grown year over year. REVB earnings in the past year totalled -$15.04 million.
Is Revelation Biosciences profitable or losing money?
As of the last Revelation Biosciences earnings report, Revelation Biosciences is currently losing money. Revelation Biosciences's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$15.04 million, a 12,405.64% increase year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.